The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine

Clin Chem Lab Med. 2023 Apr 18;61(10):e200-e202. doi: 10.1515/cclm-2023-0186. Print 2023 Sep 26.

Authors

Annagiulia Di Trana¹, Nunzia La Maida¹, Rino Froldi², Roberto Scendoni², Francesco Paolo Busardò³, Simona Pichini¹

Affiliations

¹ National Centre on Addiction and Doping, Istituto Superiore di Sanità Rome, Italy.
² Institute of Legal Medicine, Department of Law, University of Macerata, Macerata, Italy.
³ Department of Excellence of Biomedical Science and Public Health, University "Politecnica delle Marche" of Ancona, Ancona, Italy.

PMID: 37067537
DOI: 10.1515/cclm-2023-0186

No abstract available

Keywords: benzimidazole opioids; etonitazepipne; fatality; high-resolution mass spectrometry; new psychoactive substances.

Publication types

Letter

MeSH terms

Analgesics, Opioid*
Benzimidazoles*
Humans
Mass Spectrometry

Substances

Analgesics, Opioid
Benzimidazoles